Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement
-
* Corresponding author: Eric Racine eric.racine@ircm.qc.ca
1 Neuroethics Research Unit, Institut de recherches cliniques de Montréal, 110 avenue des Pins Ouest, Montréal, Québec, H2W 1R7, Canada
2 Programmes de bioéthique, Université de Montréal, Montréal, Canada
3 Department of Medicine and Department of Social and Preventive Medicine, Université de Montréal, Montréal, Canada
4 Department of Neurology and Neurosurgery and Biomedical Ethics Unit, McGill University, Montréal, Canada
BMC Medical Ethics 2009, 10:9 doi:10.1186/1472-6939-10-9
Published: 6 July 2009Additional files
Additional file 1:
Coding structure used to analyze media, bioethics, and public health discourses on the non-medical use of methylphenidate (MPH).
Format: DOC Size: 46KB Download file
This file can be viewed with: Microsoft Word Viewer
